157 related articles for article (PubMed ID: 28841814)
1. The impact of commercial rapid respiratory virus diagnostic tests on patient outcomes and health system utilization.
Ko F; Drews SJ
Expert Rev Mol Diagn; 2017 Oct; 17(10):917-931. PubMed ID: 28841814
[TBL] [Abstract][Full Text] [Related]
2. Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: a Paradigm Shift to Molecular Tests.
Azar MM; Landry ML
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29695519
[TBL] [Abstract][Full Text] [Related]
3. Point of care testing of Influenza A/B and RSV in an adult respiratory assessment unit is associated with improvement in isolation practices and reduction in hospital length of stay.
Berry L; Lansbury L; Gale L; Carroll AM; Lim WS
J Med Microbiol; 2020 May; 69(5):697-704. PubMed ID: 32250239
[No Abstract] [Full Text] [Related]
4. Rapid and simple molecular tests for the detection of respiratory syncytial virus: a review.
A Hogan C; Caya C; Papenburg J
Expert Rev Mol Diagn; 2018 Jul; 18(7):617-629. PubMed ID: 29890085
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation of four rapid antigen tests for the detection of Respiratory syncytial virus.
Jung BK; Choi SH; Lee JH; Lee J; Lim CS
J Med Virol; 2016 Oct; 88(10):1720-4. PubMed ID: 26990654
[TBL] [Abstract][Full Text] [Related]
6. Impact of Rapid Molecular Diagnostic Testing of Respiratory Viruses on Outcomes of Adults Hospitalized with Respiratory Illness: a Multicenter Quasi-experimental Study.
Wabe N; Li L; Lindeman R; Yimsung R; Dahm MR; McLennan S; Clezy K; Westbrook JI; Georgiou A
J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541934
[TBL] [Abstract][Full Text] [Related]
7. Impact of molecular point-of-care testing on clinical management and in-hospital costs of patients suspected of influenza or RSV infection: a modeling study.
Rahamat-Langendoen J; Groenewoud H; Kuijpers J; Melchers WJG; van der Wilt GJ
J Med Virol; 2019 Aug; 91(8):1408-1414. PubMed ID: 30950066
[TBL] [Abstract][Full Text] [Related]
8. Laboratory Impact of Rapid Molecular Tests used for the Detection of Respiratory Pathogens.
Lee JM; Lee JH; Kim YK
Clin Lab; 2018 Sep; 64(9):1545-1551. PubMed ID: 30274011
[TBL] [Abstract][Full Text] [Related]
9. Point-of-care diagnostics for respiratory viral infections.
Basile K; Kok J; Dwyer DE
Expert Rev Mol Diagn; 2018 Jan; 18(1):75-83. PubMed ID: 29251007
[TBL] [Abstract][Full Text] [Related]
10. Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies.
Vos LM; Bruning AHL; Reitsma JB; Schuurman R; Riezebos-Brilman A; Hoepelman AIM; Oosterheert JJ
Clin Infect Dis; 2019 Sep; 69(7):1243-1253. PubMed ID: 30689772
[TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of a rapid molecular diagnostic, MultiCode based, sample-to-answer assay for the simultaneous detection of Influenza A, B and respiratory syncytial viruses.
Voermans JJ; Seven-Deniz S; Fraaij PL; van der Eijk AA; Koopmans MP; Pas SD
J Clin Virol; 2016 Dec; 85():65-70. PubMed ID: 27835760
[TBL] [Abstract][Full Text] [Related]
12. Performance of a Novel Point-of-Care Molecular Assay for Detection of Influenza A and B Viruses and Respiratory Syncytial Virus (Enigma MiniLab) in Children with Acute Respiratory Infection.
Douthwaite ST; Walker C; Adams EJ; Mak C; Vecino Ortiz A; Martinez-Alier N; Goldenberg SD
J Clin Microbiol; 2016 Jan; 54(1):212-5. PubMed ID: 26560540
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic tests for influenza and other respiratory viruses: determining performance specifications based on clinical setting.
Takahashi H; Otsuka Y; Patterson BK
J Infect Chemother; 2010 Jun; 16(3):155-61. PubMed ID: 20191301
[TBL] [Abstract][Full Text] [Related]
14. Impact of a rapid respiratory panel test on patient outcomes.
Rogers BB; Shankar P; Jerris RC; Kotzbauer D; Anderson EJ; Watson JR; O'Brien LA; Uwindatwa F; McNamara K; Bost JE
Arch Pathol Lab Med; 2015 May; 139(5):636-41. PubMed ID: 25152311
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection.
Egilmezer E; Walker GJ; Bakthavathsalam P; Peterson JR; Gooding JJ; Rawlinson W; Stelzer-Braid S
Rev Med Virol; 2018 Sep; 28(5):e1995. PubMed ID: 30101552
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Alere i RSV for Rapid Detection of Respiratory Syncytial Virus in Children Hospitalized with Acute Respiratory Tract Infection.
Peters RM; Schnee SV; Tabatabai J; Schnitzler P; Pfeil J
J Clin Microbiol; 2017 Apr; 55(4):1032-1036. PubMed ID: 28077700
[TBL] [Abstract][Full Text] [Related]
17. Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by immunofluorescence and ELISA does not justify discontinuation of virus isolation.
Percivalle E; Zavattoni M; Revello MG; Mariani G; Scaravelli C; Gerna G
Microbiologica; 1989 Jul; 12(3):203-13. PubMed ID: 2674634
[TBL] [Abstract][Full Text] [Related]
18. Performance of the Alere i influenza A&B assay and mariPOC test for the rapid detection of influenza A and B viruses.
Jokela P; Vuorinen T; Waris M; Manninen R
J Clin Virol; 2015 Sep; 70():72-76. PubMed ID: 26305824
[TBL] [Abstract][Full Text] [Related]
19. Critical evaluation of FDA-approved respiratory multiplex assays for public health surveillance.
Diaz-Decaro JD; Green NM; Godwin HA
Expert Rev Mol Diagn; 2018 Jul; 18(7):631-643. PubMed ID: 29886764
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a fluorescent immunoassay rapid test (Sofia™) for detection of influenza A+B and RSV in a tertiary pediatric setting.
Piché-Renaud PP; Turcot J; Chartrand C; Gravel J; Labrecque M; Vallières É; Renaud C
Diagn Microbiol Infect Dis; 2016 Apr; 84(4):304-8. PubMed ID: 26827091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
